Product Information

LAMICTAL 200 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $12.0569 per EA under NDC 00173064460. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMICTAL 200 MG TABLET

lamotrigine

$12.0569per EA

High Outlier

Strength

200 mg/1

Manufacturer

GlaxoSmithKline LLC

NDC

00173064460

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LAMOTRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA020241

On Market Since

1/18/1995

Pharmacological Classes

Anti-epileptic Agent

Decreased Central Nervous System Disorganized Electrical Activity

Dihydrofolate Reductase Inhibitors

Mood Stabilizer

Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMICTAL 200 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 41.9%. The table below summarizes its recorded NADAC range and movement.

Current price	$12.0569 per EA
All-time high	$20.8537 (Oct 11, 2023)
All-time low	$8.4986 (Nov 28, 2013)
52-week high	$12.0813
52-week low	$12.0569
Median price	$15.1073
Average price	$14.9590
Largest weekly change	-43.5% (Dec 27, 2023)
Weeks tracked	657
Tracking since	Nov 28, 2013

Price History

0.0%

-0.0%

-0.1%

-0.2%

-42.2%

-33.1%

All

+41.9%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

LAMICTAL ODT 200 MG TABLET

Brand

00173077702•GlaxoSmithKline LLC

$17.4889

+45% more

Frequently asked questions

What is the NADAC price of LAMICTAL 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL 200 MG TABLET, manufactured by GlaxoSmithKline LLC, is $12.0569 per EA (NDC 00173064460), effective Jun 24, 2026.

How has the price of LAMICTAL 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMICTAL 200 MG TABLET has risen 41.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMICTAL 200 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMICTAL 200 MG TABLET has ranged from a low of $8.4986 (Nov 28, 2013) to a high of $20.8537 (Oct 11, 2023), with a median of $15.1073 per EA.

Are there cheaper alternatives to LAMICTAL 200 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as LAMICTAL 200 MG TABLET, but none are currently priced below it.